Jinzhou Xu

8PUBLICATIONS
17CO-AUTHORS
Molecular targetsElectrical energy generation (incl. renewables, excl. photovoltaics)Predictive and prognostic markersPopulation trends and policies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 02, 2026
Oncolytic virus OH2 induces PD-L1 upregulation via NF-κB signaling and synergizes with anti-PD-L1 therapy in prostate cancer through a targeted extracellular vesicle delivery system.

Jin-Zhou Xu, Ye An, Jian-Xuan Sun

|Jun 20, 2025
Efficacy of oncolytic virus in the treatment of intermediate-to-advanced solid tumors: a systematic review and meta-analysis.

Jin-Zhou Xu, Jian-Xuan Sun, Chen-Qian Liu

|Apr 15, 2025
Irreversible electroporation synergizes with oncolytic virus enhances the infiltration of cytotoxic T lymphocytes in the tumor immune microenvironment: a leap from focal therapy to immunotherapy for prostate cancer.

Zhi-Yu Xia, Jia-Cheng Xiang, Jin-Zhou Xu

|Dec 23, 2022
Association of Statin Use with the Risk of Incident Prostate Cancer: A Meta-Analysis and Systematic Review.

Meng-Yao Xu, Ye An, Chen-Qian Liu

|Nov 25, 2022
Statin Use Is Associated with Better Prognosis of Patients with Prostate Cancer after Definite Therapies: A Systematic Review and Meta-Analysis of Cohort Studies.

Ye An, Jian-Xuan Sun, Meng-Yao Xu

|Sep 22, 2022
Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy.

Yuan-Yuan Yang, Sen-Yuan Hong, Yang Xun

Pageof 2

Frequent Collaborators

8 joint publications

Shaogang Wang

6 joint publications

Qi-Dong Xia

4 joint publications

Jian-Xuan Sun

4 joint publications

Chen-Qian Liu